Smithsonian Magazine on MSN
Experimental Alzheimer's drug that fights a tough-to-target protein shows promise at slowing cognitive decline in a clinical trial
An experimental drug might slow early Alzheimer’s disease by targeting a hallmark of the illness that researchers have ...
A human biologist told Newsweek that Alzheimer's research should stop focusing on one molecule and study the wider system.
Sleeping for more than 8.5 hours a night was associated with blood biomarkers of tau protein in a new study, suggesting that excessive sleep may indicate early neurodegeneration.
When looking at geographies, the US accounts for approximately 32.7% of total activity, making it the clear leader in the ...
Intermittently inhaling a high dose of carbon dioxide seems to remove the proteins amyloid and tau, which are implicated in ...
The lipid-lowering drug obicetrapib produces the greatest reductions in the Alzheimer’s biomarker p-tau217 among APOE4 ...
3don MSN
Alzheimer's blood tests qualifications: Here's how doctors decide if you're an eligible candidate
"Good candidates are individuals who are identified as having cognitive impairment distinct from normal aging via abnormal ...
Miniature brain models grown from patients’ cells revealed striking differences in how Alzheimer’s-related tissue responds to ...
New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of ...
An experimental blood test could identify those at highest risk years before they start experiencing cognitive decline.
Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...
Celebrities diagnosed with Alzheimer’s disease include Danny Glover, Rita Hayworth, Glen Campbell and more. See what they ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results